000			03347cam a2200349 a 4500
003			EG-GiCUC
005			20250223031922.0
008			180201s2017 ua dh f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.07.Ph.D.2017.Wa.R
100	0		_aWael Mohamed Nabil Mahmoud
245	1	0	_aRole of glutathione -S-transferase Omega gene polymorphisms in childhood acute lymphoblastic leukemia / _cWael Mohamed Nabil Mahmoud ; Supervised Hanaa Hamed Arnaout , Emad Nabil Ebeid , Shahira Kamal Anis
246	1	5	_aالاشكال المتعددة لجين الجلوتاثيون ترانسفيراز أوميجا وأشتراكها مع خطر سرطان الدم الليمفاوي الحاد فى مرحلة الطفولة
260			_aCairo : _bWael Mohamed Nabil Mahmoud , _c2017
300			_a146 P. : _bcharts , facsimiles ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
520			_aPurpose The aim of our study was to investigate the role of genetic polymorphisms in Glutathione S-transferase Omega (GSTO1 and GSTO2) genes in childhood acute lymphoblastic leukemia susceptibility, and their impact on prognosis of childhood ALL patients . Methods The polymorphism of GSTO1 and GSTO2 genes were analyzed in 96 ALL patients compared with 96 healthy Egyptian children by PCR-based restriction fragment length polymorphism (RFLP) analysis. Results Genotyping of the GSTO1gene revealed no statistically significant difference in genotypes distribution between patients and control groups (p=0.106). However, when ALL cases were divided into de novo and remission groups,it was found that the frequency of homozygous and heterozygous GSTO1 mutations was significantly higher in the de novo group compared to the control group[63.0%vs 43.4% respectively, p=0.028, OR(95%CI):2.222(1.083-4.558)]. As regards The GSTO2 gene, our study demonstrated a statistically significant difference in genotypes distribution between patients and control groups; the frequency of the homozygous GSTO2 mutation was significantly higher in the de novo group compared to healthy subjects (17.3%vs 2.0%, p= 0.002 ).In addition ,the frequency of the homozygous and heterozygous GSTO2 mutation was significantly higher in the remission group compared to the control group [(82.0%vs 63.6%, p=0.012, OR(95% CI)=2.929(1.238- 6.929)]. No association was found between the presence of GSTO1 or GSTO2 mutation or their combined presence and the available bad prognostic factors (age>10 years, T-ALL phenotype, WBCs more than 50.000x10⁹/L) Conclusion We concluded that polymorphisms in the GSTO1 and O2 genes allele are present in an increased percentage of Childhood acute lymphoblastic leukemia patients. Thus it might play an important role as a genetic risk factor in development of ALL in Egyptian children
530			_aIssued also as CD
653		4	_aALL
653		4	_aGSTO genes
653		4	_aPediatrics
700	0		_aEmad Nabil Ebeid , _eSupervisor
700	0		_aHanaa Hamed Arnaout , _eSupervisor
700	0		_aShahira Kamal Anis , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShimaa _eCataloger
942			_2ddc _cTH
999			_c64782 _d64782